98%
921
2 minutes
20
The investigation and development of high thermoelectric value materials has become a research hotspot in recent years. In this work, based on the density functional theory on the Perdew-Burke-Ernzerhof (GGA-PBE) level, the thermoelectric properties of transition metal halides CdBr, Janus CdBrI, and CdI monolayers have been systematically investigated using Boltzmann transport theory. The calculation of the electronic band structure shows that these three materials have indirect band gap semiconductor properties. For carrier transport, the electron mobilities for CdBr, Janus CdBrI, and CdI monolayers are found to be 74, 16, 21 cm s V for p-type doping and 116, 102, 78 cm s V for n-type doping. Regarding their phonon transport, the CdBr, CdBrI, and CdI monolayers all have very low lattice thermal conductivity (4.78, 2.46, and 1.65 W m K, respectively) that decreases with increasing temperature, which is favorable for obtaining large values. The electrical transport results show that the performance of p-type doping is better than that of n-type doping. At 300 K, the Seebeck coefficients of p-type doping for the CdBr, CdBrI, and CdI monolayers are 217.72, 246.43, and 226.24 μV K, respectively. In addition, we predict that the values of the CdBr, CdBrI, and CdI monolayers are 0.62, 1.64, and 0.87 for p-type doping at 300 K respectively. The values increase with the increase of temperature. In particular, the Janus CdBrI monolayer has a value of 3.03 at 600 K. These results suggest that all these materials can be good candidates for thermoelectric materials.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/d3cp05613a | DOI Listing |
Infect Drug Resist
August 2025
Department of Pharmacy, Mie University Hospital, Mie, Japan.
Background: The comparative effectiveness and potential impact of individual proton pump inhibitors (PPIs) on the development of infection (CDI) remain unclear. Additionally, there is insufficient evidence to support the use of probiotics for CDI prevention outside clinical trials. This study aimed to identify the PPIs that are most associated with CDI development and to determine whether probiotic co-administration can reduce this risk.
View Article and Find Full Text PDFACS Omega
September 2025
Wuhan NARI Limited Liability Company, State Grid Electric Power Research Institute, Wuhan 430074, China.
Capacitive deionization (CDI) is a crucial technique for industries managing liquid chemical waste, requiring efficient electrode materials to ensure optimal performance. This study presents a novel undergraduate experimental teaching framework that integrates the understanding, development, and practical application of porous biochar-based CDI systems. Designed to support both students and educators, the curriculum guides learners through the synthesis of biochar electrodes via biomass pyrolysis and the assembly of CDI devices for treating phosphogypsum wastewater.
View Article and Find Full Text PDFJ Biochem Mol Toxicol
September 2025
Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA.
Microbiota, which plays a vital role in susceptibility to Clostridioides difficile infection (CDI), synthesizes butyrate. Enteric glia is a component of the enteric nervous system (ENS) and is affected by C. difficile toxins A (TcdA) and B (TcdB).
View Article and Find Full Text PDFInfect Dis Clin North Am
September 2025
Department of Microbiology, Institute for Immunology and Immune Health, University of Pennsylvania Perelman School of Medicine, 303B Johnson Pavilion, 3610 Hamilton Walk, Philadelphia, PA 19104, USA.
Clostridioides difficile infection (CDI) remains a significant cause of infectious colitis in the United States. Susceptibility to CDI is associated with perturbation of the gut microbiota, the indigenous microbes in the gastrointestinal tract. Upon colonization, the production of toxins and the ability to produce spores for environmental dissemination contribute to C difficile pathogenicity.
View Article and Find Full Text PDFInfect Dis Clin North Am
September 2025
Division of Gastroenterology & Hepatology, Department of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Electronic address:
This article offers a clinically focused overview of Clostridioides difficile infection (CDI) diagnosis, emphasizing the need to test only symptomatic patients and to distinguish true infection from colonization. It reviews multistep diagnostic algorithms that pair glutamate dehydrogenase (GDH) testing or nucleic acid amplification tests (NAAT) with toxin assays to improve accuracy. The limitations of PCR-only approaches are discussed, with a strong emphasis on clinical correlation.
View Article and Find Full Text PDF